Absci (ABSI) Interest Coverage Ratio (2020 - 2026)
Absci (ABSI) reported Interest Coverage Ratio of 3.45 for Q1 2026, up 27.9% on a YoY basis from 2.69 in Q1 2025, and up 79.39% sequentially from 16.72 in Q4 2025.
Absci (ABSI) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Absci (ABSI) has 7 years of Interest Coverage Ratio data on file, last reported at 3.45 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio rose 27.9% year-over-year to 3.45; the trailing twelve-month figure through Mar 2026 stood at 13.79 (up 29.28% YoY), and the FY2025 full-year result was 1.13, up 18.85% from the prior year.
- Interest Coverage Ratio rose to 3.45 in Q1 2026, from 16.72 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 28.31 in Q4 2022 to a low of 150.85 in Q4 2023.
- A 5-year average of 12.71 and a median of 3.85 in 2022 frame the typical range for Interest Coverage Ratio.
- Peak annual rise in Interest Coverage Ratio reached 97.23% in 2022, while the deepest fall reached 1495.07% in 2022.
- Tracing ABSI's Interest Coverage Ratio over 5 years: stood at 28.31 in 2022, then slumped by 632.79% to 150.85 in 2023, then surged by 89.1% to 16.45 in 2024, then declined by 1.67% to 16.72 in 2025, then jumped by 79.39% to 3.45 in 2026.
- Business Quant data shows ABSI's Interest Coverage Ratio at 3.45 in Q1 2026, 16.72 in Q4 2025, and 3.08 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Absci | 1.23 Bn | 1.11 Bn | - | -3.45 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.45 |
| Dec 31, 2025 | -16.72 |
| Sep 30, 2025 | -3.08 |
| Jun 30, 2025 | -5.56 |
| Mar 31, 2025 | -4.78 |
| Dec 31, 2024 | -16.45 |
| Sep 30, 2024 | -1.34 |
| Jun 30, 2024 | -2.08 |
| Mar 31, 2024 | -0.42 |
| Dec 31, 2023 | -150.85 |
| Sep 30, 2023 | -8.13 |
| Jun 30, 2023 | -14.99 |
| Mar 31, 2023 | -8.54 |
| Dec 31, 2022 | 28.31 |
| Sep 30, 2022 | -3.85 |
| Jun 30, 2022 | -3.47 |
| Mar 31, 2022 | -0.68 |
| Dec 31, 2021 | 62.96 |
| Sep 30, 2021 | -0.30 |
| Jun 30, 2021 | -0.22 |